HIV and the tuberculosis "set point": how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease
- PMID: 32967690
- PMCID: PMC7509826
- DOI: 10.1186/s12977-020-00540-2
HIV and the tuberculosis "set point": how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease
Abstract
As HIV has fueled a global resurgence of tuberculosis over the last several decades, there is a growing awareness that HIV-mediated impairments in both innate and adaptive immunity contribute to the heightened risk of tuberculosis in people with HIV. Since early immune responses to Mycobacterium tuberculosis (Mtb) set the stage for subsequent control or progression to active tuberculosis disease, early host-pathogen interactions following Mtb infection can be thought of as establishing a mycobacterial "set point," which we define as the mycobacterial burden at the point of adaptive immune activation. This early immune response is impaired in the context of HIV coinfection, allowing for a higher mycobacterial set point and greater likelihood of progression to active disease with greater bacterial burden. Alveolar macrophages, as the first cells to encounter Mtb in the lungs, play a critical role in containing Mtb growth and establishing the mycobacterial set point. However, a number of key macrophage functions, ranging from pathogen recognition and uptake to phagocytosis and microbial killing, are blunted in HIV coinfection. To date, research evaluating the effects of HIV on the alveolar macrophage response to Mtb has been relatively limited, particularly with regard to the critical early events that help to dictate the mycobacterial set point. A greater understanding of alveolar macrophage functions impacted by HIV coinfection will improve our understanding of protective immunity to Mtb and may reveal novel pathways amenable to intervention to improve both early immune control of Mtb and clinical outcomes for the millions of people worldwide infected with HIV.
Keywords: Coinfection; HIV; Innate immunity; Macrophages; Tuberculosis.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
Networked T cell death following macrophage infection by Mycobacterium tuberculosis.PLoS One. 2012;7(6):e38488. doi: 10.1371/journal.pone.0038488. Epub 2012 Jun 4. PLoS One. 2012. PMID: 22675566 Free PMC article.
-
Mycobacterium tuberculosis Infection and Innate Responses in a New Model of Lung Alveolar Macrophages.Front Immunol. 2018 Mar 12;9:438. doi: 10.3389/fimmu.2018.00438. eCollection 2018. Front Immunol. 2018. PMID: 29593716 Free PMC article.
-
Alveolar macrophages from HIV-infected subjects are resistant to Mycobacterium tuberculosis in vitro.Am J Respir Cell Mol Biol. 2004 Mar;30(3):403-10. doi: 10.1165/rcmb.2003-0059OC. Epub 2003 Sep 11. Am J Respir Cell Mol Biol. 2004. PMID: 12972398
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
-
Macrophage: A Cell With Many Faces and Functions in Tuberculosis.Front Immunol. 2022 May 6;13:747799. doi: 10.3389/fimmu.2022.747799. eCollection 2022. Front Immunol. 2022. PMID: 35603185 Free PMC article. Review.
Cited by
-
Systems biology approaches to investigate the role of granulomas in TB-HIV coinfection.Front Immunol. 2022 Oct 31;13:1014515. doi: 10.3389/fimmu.2022.1014515. eCollection 2022. Front Immunol. 2022. PMID: 36405707 Free PMC article. Review.
-
Establishment of an in vitro model of monocyte-like THP-1 cells for trained immunity induced by bacillus Calmette-Guérin.BMC Microbiol. 2024 Apr 20;24(1):130. doi: 10.1186/s12866-024-03191-x. BMC Microbiol. 2024. PMID: 38643095 Free PMC article.
-
Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment.Eur J Microbiol Immunol (Bp). 2022 Apr 14;12(1):1-17. doi: 10.1556/1886.2021.00021. Online ahead of print. Eur J Microbiol Immunol (Bp). 2022. PMID: 35420996 Free PMC article. Review.
-
Decreased IL-1 β Secretion as a Potential Predictor of Tuberculosis Recurrence in Individuals Diagnosed with HIV.Biomedicines. 2024 Apr 25;12(5):954. doi: 10.3390/biomedicines12050954. Biomedicines. 2024. PMID: 38790916 Free PMC article.
-
Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report.Ann Am Thorac Soc. 2023 Mar;20(3):341-353. doi: 10.1513/AnnalsATS.202212-1019ST. Ann Am Thorac Soc. 2023. PMID: 36856712 Free PMC article.
References
-
- Murray JF, Schraufnagel DE, Hopewell PC. Treatment of tuberculosis. A historical perspective. Ann Am Thoracic Soc. 2015;12(12):1749–1759. - PubMed
-
- Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet. 1995;345(8964):1545–1548. - PubMed
-
- Enarson DA. Principles of IUATLD collaborative tuberculosis progammes. Bull Int Union Against Tuberc Lung Dis. 1991;66(4):195–200. - PubMed
-
- Iseman MD. Tuberculosis therapy: past, present and future. Eur Respir J. 2002;20(36 suppl):87S–94s. - PubMed
-
- Centers for Disease Control Pneumocystis pneumonia–Los Angeles. MMWR Morb Mortal Wkly Rep. 1981;30(21):250–252. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials